LifeSiteNews.com

Tuesday August 9, 2005



     

FDA to announce Morning-After Pill Decision by end of August

WASHINGTON, August 9, 2005 (LifeSiteNews.com) – The US Food and Drug Administration said it would decide the fate of Barr Pharmaceuticals Plan B abortifacient morning-after pill by month’s end.

The FDA denied Barr’s first attempt at over-the-counter approval last year, based on the “overwhelming recommendation of the agency's own scientific advisers,” according to a CNN report. In addition, the FDA expressed concern that Barr had not included any age restriction in the application. Their updated application requested that the drug be available OTC for girls aged 16 or over, while prescription-only status be retained for girls under 16.

Experts argue that making the pills more accessible could lead to teens engaging in activities they might otherwise not do, based on the false sense of security inherent with availability of the pill. The increased availability of the pill also raises concerns over increased exposure to sexually transmitted disease, in turn sparking a significant increase in cancer, infertility, and HIV/AIDS.

The Bangkok Post reported in 2002 that several random studies revealed that men are the most frequent buyers of morning-after pills, using them to exploit women. “Although many feminists believe that the morning-after pill gives them more control over their own bodies, it would seem, judging from the few studies conducted so far, that it is actually being used by men to exploit women,” the paper’s author concluded.

Read related LifeSiteNews.com coverage:
Scottish Research "Discovers" Morning-After Pill Does Not Reduce Abortion Rate http://www.lifesitenews.com/ldn/2004/dec/04120304.html
Pharmaceutical tries again for FDA Approval of Morning After Pill Without Prescription http://www.lifesitenews.com/ldn/2004/jul/04072306.html
Morning After Pills Used To Exploit Women And Create Serious Health Risks http://www.lifesitenews.com/ldn/2002/jun/02061005.html

tv

Back to Top Back to Top


SHARE THIS STORY: E-mail  Print  Newsvine  Digg  Reddit  Del.icio.us  Facebook



MORE NEWS: LifeSiteNews.com Home Page  Last 10 Days   Archives   Special Reports

Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.